These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 15677486

  • 21. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.
    Yan F, Hui YN, Li YJ, Guo CM, Meng H.
    Ophthalmologica; 2007; 221(4):244-50. PubMed ID: 17579290
    [Abstract] [Full Text] [Related]

  • 22. Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of huntington disease.
    Guzhova IV, Lazarev VF, Kaznacheeva AV, Ippolitova MV, Muronetz VI, Kinev AV, Margulis BA.
    Hum Mol Genet; 2011 Oct 15; 20(20):3953-63. PubMed ID: 21775503
    [Abstract] [Full Text] [Related]

  • 23. Polyglutamine expansion of huntingtin impairs its nuclear export.
    Cornett J, Cao F, Wang CE, Ross CA, Bates GP, Li SH, Li XJ.
    Nat Genet; 2005 Feb 15; 37(2):198-204. PubMed ID: 15654337
    [Abstract] [Full Text] [Related]

  • 24. A huntingtin peptide inhibits polyQ-huntingtin associated defects.
    Arribat Y, Bonneaud N, Talmat-Amar Y, Layalle S, Parmentier ML, Maschat F.
    PLoS One; 2013 Feb 15; 8(7):e68775. PubMed ID: 23861941
    [Abstract] [Full Text] [Related]

  • 25. Sir2 is induced by oxidative stress in a yeast model of Huntington disease and its activation reduces protein aggregation.
    Sorolla MA, Nierga C, Rodríguez-Colman MJ, Reverter-Branchat G, Arenas A, Tamarit J, Ros J, Cabiscol E.
    Arch Biochem Biophys; 2011 Jun 01; 510(1):27-34. PubMed ID: 21513696
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding.
    Xiao G, Fan Q, Wang X, Zhou B.
    Proc Natl Acad Sci U S A; 2013 Sep 10; 110(37):14995-5000. PubMed ID: 23980182
    [Abstract] [Full Text] [Related]

  • 28. [Histone deacetylase inhibitors as therapeutic agents for polyglutamine disorders].
    Jiang H, Jia D, Tang B.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb 10; 27(1):52-5. PubMed ID: 20140868
    [Abstract] [Full Text] [Related]

  • 29. Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase.
    Scappini E, Koh TW, Martin NP, O'Bryan JP.
    Hum Mol Genet; 2007 Aug 01; 16(15):1862-71. PubMed ID: 17550941
    [Abstract] [Full Text] [Related]

  • 30. Disruption of the toxic conformation of the expanded polyglutamine stretch leads to suppression of aggregate formation and cytotoxicity.
    Popiel HA, Nagai Y, Onodera O, Inui T, Fujikake N, Urade Y, Strittmatter WJ, Burke JR, Ichikawa A, Toda T.
    Biochem Biophys Res Commun; 2004 May 14; 317(4):1200-6. PubMed ID: 15094397
    [Abstract] [Full Text] [Related]

  • 31. Deactivation of TBP contributes to SCA17 pathogenesis.
    Hsu TC, Wang CK, Yang CY, Lee LC, Hsieh-Li HM, Ro LS, Chen CM, Lee-Chen GJ, Su MT.
    Hum Mol Genet; 2014 Dec 20; 23(25):6878-93. PubMed ID: 25104854
    [Abstract] [Full Text] [Related]

  • 32. Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila.
    Marsh JL, Walker H, Theisen H, Zhu YZ, Fielder T, Purcell J, Thompson LM.
    Hum Mol Genet; 2000 Jan 01; 9(1):13-25. PubMed ID: 10587574
    [Abstract] [Full Text] [Related]

  • 33. RACK1 modulates polyglutamine-induced neurodegeneration by promoting ERK degradation in Drosophila.
    Xie J, Han Y, Wang T.
    PLoS Genet; 2021 May 01; 17(5):e1009558. PubMed ID: 33983927
    [Abstract] [Full Text] [Related]

  • 34. Pathogenic Huntington Alters BMP Signaling and Synaptic Growth through Local Disruptions of Endosomal Compartments.
    Akbergenova Y, Littleton JT.
    J Neurosci; 2017 Mar 22; 37(12):3425-3439. PubMed ID: 28235896
    [Abstract] [Full Text] [Related]

  • 35. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila.
    Gunawardena S, Her LS, Brusch RG, Laymon RA, Niesman IR, Gordesky-Gold B, Sintasath L, Bonini NM, Goldstein LS.
    Neuron; 2003 Sep 25; 40(1):25-40. PubMed ID: 14527431
    [Abstract] [Full Text] [Related]

  • 36. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration.
    Hirabayashi M, Inoue K, Tanaka K, Nakadate K, Ohsawa Y, Kamei Y, Popiel AH, Sinohara A, Iwamatsu A, Kimura Y, Uchiyama Y, Hori S, Kakizuka A.
    Cell Death Differ; 2001 Oct 25; 8(10):977-84. PubMed ID: 11598795
    [Abstract] [Full Text] [Related]

  • 37. Essential fatty acids in Huntington's disease.
    Das UN, Vaddadi KS.
    Nutrition; 2004 Oct 25; 20(10):942-7. PubMed ID: 15474886
    [Abstract] [Full Text] [Related]

  • 38. Analyzing the aggregation of polyglutamine-expansion proteins and its modulation by molecular chaperones.
    Kubota H, Kitamura A, Nagata K.
    Methods; 2011 Mar 25; 53(3):267-74. PubMed ID: 21195182
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.